The United States approved emergency approval this Saturdayn treatment with synthetic antibodies against the Covid-19 company Regeneron, which was used to treat President Donald Trump when he contracted the coronavirus.

“Licensing these therapies with monoclonal antibodies can help outpatients avoid hospitalization and ease the burden on our health care system, ”said Stephen Hahn, commissioner of the U.S. Food and Drug Administration (FDA).

The drug is designed to prevent those infected with the coronavirus from developing a serious disease, Infobae says. The medium adds that instead of waiting for the body to develop an immune response, the drug mimics the body’s natural defenses.

This would be another monoclonal drug, used to combat covid-19.

As the FDA noted after approving an antibody cocktail, it can be effective in treatment mild to moderate in adults and children older than 12 years. It would also be indicated for people at high risk of developing a serious illness.